These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 1848168)
21. Effects of ranitidine on plasma clearance of indocyanine green in patients with liver cirrhosis. Kosaka Y; Tameda Y; Okita K; Takemoto T; Sato S; Okuda K; Kameda H; Yamamoto S; Kamada T; Muto Y Gastroenterol Jpn; 1987 Dec; 22(6):737-42. PubMed ID: 3443254 [TBL] [Abstract][Full Text] [Related]
22. The estimation of hepatic blood flow with indocyanine green: comparison between the continuous infusion and single injection methods. Villeneuve JP; Huot R; Marleau D; Huet PM Am J Gastroenterol; 1982 Apr; 77(4):233-7. PubMed ID: 7072694 [TBL] [Abstract][Full Text] [Related]
23. The effect of ranitidine on the plasma clearance and hepatic extraction of indocyanine green in patients with chronic liver disease. Dunk AA; Jenkins WJ; Burroughs AK; Walt RP; Osuafor TO; Sherlock S; Mackie S; Dick R Br J Clin Pharmacol; 1983 Aug; 16(2):117-20. PubMed ID: 6137230 [TBL] [Abstract][Full Text] [Related]
24. Cefoperazone pharmacokinetics in patients with liver cirrhosis: a predictive value of the ujoviridin test. Saudek F; Morávek J; Modr Z Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):82-7. PubMed ID: 2921099 [TBL] [Abstract][Full Text] [Related]
25. Preliminary study of indocyanine green clearance in primary biliary cirrhosis. Clements D; Elias E; McMaster P Scand J Gastroenterol; 1991 Jan; 26(1):119-23. PubMed ID: 2006392 [TBL] [Abstract][Full Text] [Related]
26. Beta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution. Avram MJ; Krejcie TC; Henthorn TK; Niemann CU J Pharmacol Exp Ther; 2004 Nov; 311(2):617-24. PubMed ID: 15197245 [TBL] [Abstract][Full Text] [Related]
27. Clinical applications of ICG Finger Monitor in patients with liver disease. Ishigami Y; Masuzawa M; Miyoshi E; Kato M; Tamura K; Kanda M; Awazu K; Taniguchi K; Kurita M; Hayashi N J Hepatol; 1993 Sep; 19(2):232-40. PubMed ID: 8301056 [TBL] [Abstract][Full Text] [Related]
28. [The effects of verapamil and nifedipine on the biotransformation of model substances and on the indocyanine green elimination]. Sigusch H; Henschel L; Hoffmann A Gastroenterol J; 1991; 51(1):33-6. PubMed ID: 1910493 [TBL] [Abstract][Full Text] [Related]
29. Use of indocyanine green dye clearance in a patient with liver cirrhosis undergoing hepatectomy: a clinical image. Weinberg L; Robinson C; Goh SK; Muralidharan V BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29950373 [No Abstract] [Full Text] [Related]
30. Evidence of the intact hepatocyte theory in alcoholic cirrhosis. Vaubourdolle M; Gufflet V; Guechot J; Ballet F; Jaillon P; Giboudeau J; Poupon R Scand J Gastroenterol; 1989 May; 24(4):467-74. PubMed ID: 2781241 [TBL] [Abstract][Full Text] [Related]
31. Lactate is correlated with the indocyanine green elimination rate in liver resection for cirrhotic patients. Orii R; Sugawara Y; Hayashida M; Uchida K; Yamada Y; Takayama T; Makuuchi M; Hanaoka K Anesth Analg; 2001 Apr; 92(4):1064-70. PubMed ID: 11273952 [TBL] [Abstract][Full Text] [Related]
32. Direct measurement of hepatic indocyanine green clearance with near-infrared spectroscopy: separate evaluation of uptake and removal. Shinohara H; Tanaka A; Kitai T; Yanabu N; Inomoto T; Satoh S; Hatano E; Yamaoka Y; Hirao K Hepatology; 1996 Jan; 23(1):137-44. PubMed ID: 8550033 [TBL] [Abstract][Full Text] [Related]
33. Effect of liver blood flow and function on hepatic indocyanine green clearance measured directly in a cirrhotic animal model. Jiao LR; El-Desoky AA; Seifalian AM; Habib N; Davidson BR Br J Surg; 2000 May; 87(5):568-74. PubMed ID: 10792311 [TBL] [Abstract][Full Text] [Related]
34. Indocyanine green clearance reflects reperfusion injury following liver transplantation and is an early predictor of graft function. Plevris JN; Jalan R; Bzeizi KI; Dollinger MM; Lee A; Garden OJ; Hayes PC J Hepatol; 1999 Jan; 30(1):142-8. PubMed ID: 9927161 [TBL] [Abstract][Full Text] [Related]
35. Interpretation of simultaneous measurements of hepatic extraction fractions of indocyanine green and sorbitol: evidence of hepatic shunts and capillarization? Ott P; Clemmesen O; Keiding S Dig Dis Sci; 2000 Feb; 45(2):359-65. PubMed ID: 10711452 [TBL] [Abstract][Full Text] [Related]
36. Hepatic removal of two fractions of indocyanine green after bolus injection in anesthetized pigs. Ott P; Keiding S; Johnsen AH; Bass L Am J Physiol; 1994 Jun; 266(6 Pt 1):G1108-22. PubMed ID: 8023942 [TBL] [Abstract][Full Text] [Related]
37. Assessment of the hepatic circulation in humans: new concepts based on evidence derived from a D-sorbitol clearance method. Molino G; Avagnina P; Belforte G; Bircher J J Lab Clin Med; 1998 May; 131(5):393-405. PubMed ID: 9605103 [TBL] [Abstract][Full Text] [Related]
38. Normal metabolism of morphine in cirrhosis. Patwardhan RV; Johnson RF; Hoyumpa A; Sheehan JJ; Desmond PV; Wilkinson GR; Branch RA; Schenker S Gastroenterology; 1981 Dec; 81(6):1006-11. PubMed ID: 7286578 [TBL] [Abstract][Full Text] [Related]
39. Prostaglandin E1 increases indocyanine green disappearance rate in patients with chronic liver disease. Aono T; Sakaguchi T; Tsukada K; Fujita N; Ishiduka D; Hatakeyama K J Int Med Res; 1995; 23(4):299-307. PubMed ID: 7589774 [TBL] [Abstract][Full Text] [Related]
40. Half-life time or clearance of indocyanine green in patients with liver disease. Gilmore IT; Marigold JH; Thompson RP Hepatogastroenterology; 1982 Apr; 29(2):55-7. PubMed ID: 7084884 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]